$4.71 Billion is the total value of Orbimed Advisors's 128 reported holdings in Q3 2023. The portfolio turnover from Q2 2023 to Q3 2023 was 35.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
SVA | SINOVAC BIOTECH LTD | $340,000,000 | 0.0% | 2,718,735 | 0.0% | 7.22% | +17.2% | |
BSX | Sell | BOSTON SCIENTIFIC CORP | $174,599,040 | -4.5% | 3,306,800 | -2.2% | 3.71% | +12.0% |
HUM | Sell | HUMANA INC | $166,633,100 | +6.9% | 342,500 | -1.8% | 3.54% | +25.3% |
ISRG | Sell | INTUITIVE SURGICAL INC | $145,852,710 | -31.3% | 499,000 | -19.6% | 3.10% | -19.4% |
BIIB | BIOGEN INC | $143,103,168 | -9.8% | 556,800 | 0.0% | 3.04% | +5.8% | |
BMRN | BIOMARIN PHARMACEUTICAL INC | $142,913,781 | +2.1% | 1,615,210 | 0.0% | 3.04% | +19.7% | |
ENLIVEN THERAPEUTICS INC | $122,917,297 | -33.1% | 8,998,338 | 0.0% | 2.61% | -21.5% | ||
MRK | New | MERCK & CO INC | $108,612,250 | – | 1,055,000 | +100.0% | 2.31% | – |
DISC MEDICINE INC | $106,627,546 | +5.8% | 2,269,637 | 0.0% | 2.26% | +24.0% | ||
LLY | ELI LILLY & CO | $99,906,180 | +14.5% | 186,000 | 0.0% | 2.12% | +34.2% | |
IONS | IONIS PHARMACEUTICALS INC | $98,408,520 | +10.6% | 2,169,500 | 0.0% | 2.09% | +29.6% | |
SWTX | Sell | SPRINGWORKS THERAPEUTICS INC | $91,753,755 | -16.3% | 3,968,588 | -5.0% | 1.95% | -1.8% |
UTHR | UNITED THERAPEUTICS CORP DEL | $90,777,153 | +2.3% | 401,900 | 0.0% | 1.93% | +19.9% | |
CRNX | Sell | CRINETICS PHARMACEUTICALS IN | $86,129,241 | +21.0% | 2,896,074 | -26.7% | 1.83% | +41.9% |
MRTX | Buy | MIRATI THERAPEUTICS INC | $85,336,218 | +158.5% | 1,959,050 | +114.4% | 1.81% | +203.2% |
BAX | Sell | BAXTER INTL INC | $84,533,826 | -45.0% | 2,239,900 | -33.6% | 1.80% | -35.5% |
EWTX | EDGEWISE THERAPEUTICS INC | $83,469,918 | -26.1% | 14,567,176 | 0.0% | 1.77% | -13.3% | |
THC | Buy | TENET HEALTHCARE CORP | $80,675,716 | +3.2% | 1,224,400 | +27.5% | 1.71% | +21.0% |
XTNT | XTANT MED HLDGS INC | $80,426,051 | +18.3% | 73,114,592 | 0.0% | 1.71% | +38.6% | |
EVH | EVOLENT HEALTH INCcl a | $78,848,059 | -10.1% | 2,895,632 | 0.0% | 1.68% | +5.3% | |
SYK | Sell | STRYKER CORPORATION | $73,509,630 | -11.2% | 269,000 | -0.9% | 1.56% | +4.1% |
TMO | Sell | THERMO FISHER SCIENTIFIC INC | $72,787,246 | -14.3% | 143,800 | -11.7% | 1.55% | +0.5% |
Buy | APOLLOMICS INC | $67,386,163 | +1675.0% | 17,993,635 | +2615.8% | 1.43% | +1973.9% | |
CI | Buy | THE CIGNA GROUP | $66,225,205 | +46.6% | 231,500 | +43.8% | 1.41% | +71.8% |
SRPT | Sell | SAREPTA THERAPEUTICS INC | $64,149,624 | -14.3% | 529,200 | -19.1% | 1.36% | +0.4% |
VRNA | VERONA PHARMA PLCsponsored ads | $61,577,781 | -22.9% | 3,777,778 | 0.0% | 1.31% | -9.6% | |
New | RAYZEBIO INC | $58,228,580 | – | 2,622,909 | +100.0% | 1.24% | – | |
VRTX | VERTEX PHARMACEUTICALS INC | $57,516,196 | -1.2% | 165,400 | 0.0% | 1.22% | +15.8% | |
ACELYRIN INC | $54,168,491 | -51.3% | 5,326,302 | 0.0% | 1.15% | -42.9% | ||
R1 RCM INC | $51,855,870 | -18.3% | 3,441,000 | 0.0% | 1.10% | -4.2% | ||
PCVX | VAXCYTE INC | $51,344,405 | +2.1% | 1,007,148 | 0.0% | 1.09% | +19.8% | |
ABBV | New | ABBVIE INC | $49,189,800 | – | 330,000 | +100.0% | 1.04% | – |
SIBN | SI-BONE INC | $48,693,358 | -21.3% | 2,292,531 | 0.0% | 1.03% | -7.8% | |
KROS | KEROS THERAPEUTICS INC | $48,289,720 | -20.7% | 1,514,734 | 0.0% | 1.03% | -7.0% | |
APLS | Buy | APELLIS PHARMACEUTICALS INC | $47,949,420 | -42.2% | 1,260,500 | +38.5% | 1.02% | -32.2% |
Buy | THESEUS PHARMACEUTICALS INC | $47,649,584 | -70.4% | 17,713,600 | +2.8% | 1.01% | -65.3% | |
NBIX | Sell | NEUROCRINE BIOSCIENCES INC | $46,788,750 | +1.5% | 415,900 | -14.9% | 0.99% | +18.9% |
ALPN | ALPINE IMMUNE SCIENCES INC | $46,734,228 | +11.4% | 4,081,592 | 0.0% | 0.99% | +30.7% | |
Buy | PRELUDE THERAPEUTICS INCnonvoting | $45,127,757 | -32.0% | 12,048,773 | +1.3% | 0.96% | -20.2% | |
CMPX | COMPASS THERAPEUTICS INC | $44,054,815 | -38.1% | 22,362,850 | 0.0% | 0.94% | -27.4% | |
NTRA | Sell | NATERA INC | $40,735,709 | -14.0% | 920,581 | -5.4% | 0.86% | +0.8% |
PMVP | PMV PHARMACEUTICALS INC | $40,297,293 | -1.9% | 6,563,077 | 0.0% | 0.86% | +15.1% | |
RPTX | REPARE THERAPEUTICS INC | $40,135,655 | +14.2% | 3,322,488 | 0.0% | 0.85% | +33.9% | |
SCPH | SCPHARMACEUTICALS INC | $39,583,839 | -30.1% | 5,559,528 | 0.0% | 0.84% | -18.0% | |
NPCE | NEUROPACE INC | $39,039,494 | +116.7% | 4,012,281 | 0.0% | 0.83% | +154.3% | |
TERN | TERNS PHARMACEUTICALS INC | $38,324,249 | -42.5% | 7,619,135 | 0.0% | 0.81% | -32.6% | |
MDGL | Sell | MADRIGAL PHARMACEUTICALS INC | $36,993,246 | -50.2% | 253,309 | -21.2% | 0.79% | -41.6% |
THIRD HARMONIC BIO INC | $36,928,264 | +32.8% | 5,779,071 | 0.0% | 0.78% | +55.6% | ||
UNH | Sell | UNITEDHEALTH GROUP INC | $35,293,300 | -69.9% | 70,000 | -71.3% | 0.75% | -64.7% |
SBTX | Buy | ARS PHARMACEUTICALS INC | $34,930,553 | -40.4% | 9,240,887 | +5.7% | 0.74% | -30.1% |
AMGN | AMGEN INC | $34,213,148 | +21.1% | 127,300 | 0.0% | 0.73% | +42.0% | |
PRLD | PRELUDE THERAPEUTICS INC | $33,709,601 | -31.3% | 10,909,256 | 0.0% | 0.72% | -19.6% | |
JANX | Buy | JANUX THERAPEUTICS INC | $33,444,704 | -0.7% | 3,317,927 | +17.0% | 0.71% | +16.4% |
XENE | Sell | XENON PHARMACEUTICALS INC | $32,752,369 | -22.4% | 958,793 | -12.5% | 0.70% | -9.0% |
ICLR | New | ICON PLC | $32,554,250 | – | 132,200 | +100.0% | 0.69% | – |
HZNP | Sell | HORIZON THERAPEUTICS PUB L | $30,819,816 | -5.3% | 266,400 | -15.8% | 0.66% | +11.0% |
New | APOGEE THERAPEUTICS INC | $30,414,291 | – | 1,427,901 | +100.0% | 0.65% | – | |
GRCL | Buy | GRACELL BIOTECHNOLOGIES INCsponsored ads | $26,809,131 | -22.1% | 9,308,726 | +3.0% | 0.57% | -8.8% |
TELA | TELA BIO INC | $22,684,336 | -21.0% | 2,835,542 | 0.0% | 0.48% | -7.3% | |
IOVA | IOVANCE BIOTHERAPEUTICS INC | $21,418,934 | -35.4% | 4,707,458 | 0.0% | 0.46% | -24.2% | |
New | NEUMORA THERAPEUTICS INC. | $21,165,000 | – | 1,500,000 | +100.0% | 0.45% | – | |
VERA | Sell | VERA THERAPEUTICS INCcl a | $20,813,357 | -26.2% | 1,518,115 | -13.6% | 0.44% | -13.5% |
RAPT | Sell | RAPT THERAPEUTICS INC | $20,690,986 | -11.6% | 1,244,945 | -0.5% | 0.44% | +3.8% |
ABCL | ABCELLERA BIOLOGICS INC | $19,231,533 | -28.8% | 4,180,768 | 0.0% | 0.41% | -16.4% | |
SNDX | Sell | SYNDAX PHARMACEUTICALS INC | $18,643,680 | -64.8% | 1,284,000 | -49.3% | 0.40% | -58.8% |
AKRO | Buy | AKERO THERAPEUTICS INC | $17,703,000 | +90.1% | 350,000 | +75.4% | 0.38% | +122.5% |
AZN | New | ASTRAZENECA PLCcall | $16,930,000 | – | 250,000 | +100.0% | 0.36% | – |
ARGX | ARGENX SEsponsored adr | $16,027,138 | +26.1% | 32,600 | 0.0% | 0.34% | +47.8% | |
SRRK | Buy | SCHOLAR ROCK HLDG CORP | $14,439,902 | +160.3% | 2,033,789 | +176.5% | 0.31% | +204.0% |
QURE | UNIQURE NV | $13,852,493 | -41.4% | 2,064,455 | 0.0% | 0.29% | -31.5% | |
IKNA | IKENA ONCOLOGY INC | $13,796,099 | -34.0% | 3,186,166 | 0.0% | 0.29% | -22.7% | |
ALXO | ALX ONCOLOGY HLDGS INC | $13,780,800 | -36.1% | 2,871,000 | 0.0% | 0.29% | -25.1% | |
RYTM | New | RHYTHM PHARMACEUTICALS INC | $13,379,993 | – | 583,642 | +100.0% | 0.28% | – |
VERASTEM INC | $12,431,705 | +9.3% | 1,529,115 | 0.0% | 0.26% | +28.2% | ||
New | TURNSTONE BIOLOGICS CORP | $12,211,104 | – | 3,099,265 | +100.0% | 0.26% | – | |
IMTX | Buy | IMMATICS N.V | $12,161,316 | +9.0% | 1,050,200 | +8.6% | 0.26% | +27.7% |
Sell | VENTYX BIOSCIENCES INC | $11,821,536 | -33.4% | 340,384 | -37.1% | 0.25% | -22.0% | |
ARWR | Buy | ARROWHEAD PHARMACEUTICALS IN | $11,652,202 | +179.3% | 433,651 | +270.6% | 0.25% | +226.3% |
ACET | ADICET BIO INC | $11,401,332 | -43.6% | 8,322,140 | 0.0% | 0.24% | -33.9% | |
KNTE | KINNATE BIOPHARMA INC | $11,213,621 | -53.8% | 8,009,729 | 0.0% | 0.24% | -45.9% | |
REGN | REGENERON PHARMACEUTICALS | $11,109,960 | +14.5% | 13,500 | 0.0% | 0.24% | +34.1% | |
SGEN | New | SEAGEN INCcall | $10,607,500 | – | 50,000 | +100.0% | 0.22% | – |
AVTE | AEROVATE THERAPEUTICS INC | $10,271,540 | -20.9% | 756,930 | 0.0% | 0.22% | -7.2% | |
ARQT | ARCUTIS BIOTHERAPEUTICS INC | $10,165,883 | -44.3% | 1,914,479 | 0.0% | 0.22% | -34.7% | |
CRVS | CORVUS PHARMACEUTICALS INC | $10,137,735 | -36.2% | 6,943,654 | 0.0% | 0.22% | -25.3% | |
SGEN | New | SEAGEN INC | $9,037,590 | – | 42,600 | +100.0% | 0.19% | – |
GDRX | Sell | GOODRX HLDGS INC | $8,979,850 | -9.0% | 1,595,000 | -10.8% | 0.19% | +6.7% |
INVIVYD INC | $8,959,680 | +61.9% | 5,270,400 | 0.0% | 0.19% | +90.0% | ||
FUSN | FUSION PHARMACEUTICALS INC | $8,119,202 | -44.3% | 3,122,770 | 0.0% | 0.17% | -34.8% | |
XFOR | X4 PHARMACEUTICALS INC | $7,775,531 | -43.8% | 7,133,515 | 0.0% | 0.16% | -34.3% | |
GILD | GILEAD SCIENCES INC | $7,494,000 | -2.8% | 100,000 | 0.0% | 0.16% | +13.6% | |
PASG | PASSAGE BIO INC | $6,661,971 | -30.1% | 10,124,576 | 0.0% | 0.14% | -17.9% | |
MOONLAKE IMMUNOTHERAPEUTICSclass a ord | $6,669,000 | +11.8% | 117,000 | 0.0% | 0.14% | +31.5% | ||
KZR | KEZAR LIFE SCIENCES INC | $6,500,970 | -51.4% | 5,463,000 | 0.0% | 0.14% | -43.2% | |
New | KENVUE INC | $6,273,072 | – | 312,404 | +100.0% | 0.13% | – | |
NSPR | INSPIREMD INC | $6,083,524 | +30.3% | 1,860,405 | 0.0% | 0.13% | +51.8% | |
ORIC | Sell | ORIC PHARMACEUTICALS INC | $5,406,691 | -40.4% | 893,668 | -23.5% | 0.12% | -29.9% |
New | KENVUE INCcall | $5,020,000 | – | 250,000 | +100.0% | 0.11% | – | |
CGEM | CULLINAN ONCOLOGY INC | $4,930,874 | -15.9% | 544,848 | 0.0% | 0.10% | -0.9% | |
MORF | MORPHIC HLDG INC | $4,776,735 | -60.0% | 208,500 | 0.0% | 0.10% | -53.5% | |
DXCM | New | DEXCOM INCcall | $4,665,000 | – | 50,000 | +100.0% | 0.10% | – |
MRTX | New | MIRATI THERAPEUTICS INCcall | $4,356,000 | – | 100,000 | +100.0% | 0.09% | – |
RLAY | New | RELAY THERAPEUTICS INC | $4,221,534 | – | 501,966 | +100.0% | 0.09% | – |
CUTR | Buy | CUTERA INC | $3,630,662 | -38.0% | 603,100 | +55.8% | 0.08% | -27.4% |
Buy | YS BIOPHARMA CO LTDordinary shares | $3,633,138 | -38.8% | 4,541,422 | +5.7% | 0.08% | -28.0% | |
NXTC | NEXTCURE INC | $3,497,207 | -28.3% | 2,711,013 | 0.0% | 0.07% | -15.9% | |
APLS | New | APELLIS PHARMACEUTICALS INCcall | $2,948,100 | – | 77,500 | +100.0% | 0.06% | – |
EPIX | Sell | ESSA PHARMA INC | $2,602,911 | +4.6% | 842,366 | -8.6% | 0.06% | +22.2% |
VIGIL NEUROSCIENCE INC | $2,419,522 | -42.7% | 448,891 | 0.0% | 0.05% | -32.9% | ||
KRTX | New | KARUNA THERAPEUTICS INC | $2,367,260 | – | 14,000 | +100.0% | 0.05% | – |
CMMB | CHEMOMAB THERAPEUTICS LTDsponsored ads | $2,005,940 | -31.9% | 2,241,274 | 0.0% | 0.04% | -18.9% | |
TDOC | New | TELADOC HEALTH INC | $2,044,900 | – | 110,000 | +100.0% | 0.04% | – |
AFIB | ACUTUS MED INC | $1,844,866 | -21.6% | 2,648,386 | 0.0% | 0.04% | -9.3% | |
BCAB | Sell | BIOATLA INC | $1,715,774 | -50.5% | 1,009,279 | -12.7% | 0.04% | -42.9% |
PHGE | BIOMX INC | $1,602,828 | -2.2% | 4,553,489 | 0.0% | 0.03% | +13.3% | |
BOLT | BOLT BIOTHERAPEUTICS INC | $1,602,640 | -18.8% | 1,541,000 | 0.0% | 0.03% | -5.6% | |
IMTX | New | IMMATICS N.Vcall | $1,447,500 | – | 125,000 | +100.0% | 0.03% | – |
TARA | PROTARA THERAPEUTICS INC | $1,290,215 | -30.1% | 772,584 | 0.0% | 0.03% | -18.2% | |
New | SYNLOGIC INC | $1,129,614 | – | 401,998 | +100.0% | 0.02% | – | |
ELEV | ELEVATION ONCOLOGY INC | $993,900 | -56.4% | 1,500,000 | 0.0% | 0.02% | -48.8% | |
HRTX | HERON THERAPEUTICS INC | $826,781 | -11.2% | 802,700 | 0.0% | 0.02% | +5.9% | |
CALCIMEDICA INC | $790,882 | -33.7% | 297,380 | 0.0% | 0.02% | -22.7% | ||
GLTO | Sell | GALECTO INC | $665,385 | -93.1% | 924,788 | -75.9% | 0.01% | -92.0% |
XNCR | New | XENCOR INC | $385,711 | – | 19,142 | +100.0% | 0.01% | – |
ALT | ALTIMMUNE INC | $260,000 | -26.3% | 100,000 | 0.0% | 0.01% | 0.0% | |
New | HARPOON THERAPEUTICS INC | $250,348 | – | 62,121 | +100.0% | 0.01% | – | |
OMIC | SINGULAR GENOMICS SYSTEMS IN | $206,006 | -54.1% | 540,697 | 0.0% | 0.00% | -50.0% | |
NKTR | Exit | NEKTAR THERAPEUTICScall | $0 | – | -515,000 | -100.0% | -0.01% | – |
HARP | Exit | HARPOON THERAPEUTICS INC | $0 | – | -621,218 | -100.0% | -0.01% | – |
MRSN | Exit | MERSANA THERAPEUTICS INCcall | $0 | – | -250,000 | -100.0% | -0.02% | – |
TGTX | Exit | TG THERAPEUTICS INCcall | $0 | – | -45,800 | -100.0% | -0.02% | – |
RVNC | Exit | REVANCE THERAPEUTICS INC | $0 | – | -100,000 | -100.0% | -0.05% | – |
SYBX | Exit | SYNLOGIC INC | $0 | – | -6,029,995 | -100.0% | -0.05% | – |
ALKS | Exit | ALKERMES PLC | $0 | – | -151,400 | -100.0% | -0.09% | – |
HZNP | Exit | HORIZON THERAPEUTICS PUB Lput | $0 | – | -50,000 | -100.0% | -0.09% | – |
THC | Exit | TENET HEALTHCARE CORPcall | $0 | – | -100,000 | -100.0% | -0.15% | – |
GHRS | Exit | GH RESEARCH PLCordinary shares | $0 | – | -736,315 | -100.0% | -0.16% | – |
Exit | BRIDGEBIO PHARMA INCnote 2.250% 2/0 | $0 | – | -15,000,000 | -100.0% | -0.17% | – | |
HUM | Exit | HUMANA INCcall | $0 | – | -25,000 | -100.0% | -0.20% | – |
BAX | Exit | BAXTER INTL INCcall | $0 | – | -300,000 | -100.0% | -0.25% | – |
DBTX | Exit | DECIBEL THERAPEUTICS INC | $0 | – | -4,945,192 | -100.0% | -0.34% | – |
FOLD | Exit | AMICUS THERAPEUTICS INC | $0 | – | -1,856,400 | -100.0% | -0.42% | – |
MRSN | Exit | MERSANA THERAPEUTICS INC | $0 | – | -7,214,937 | -100.0% | -0.43% | – |
Exit | 2SEVENTY BIO INC | $0 | – | -2,391,628 | -100.0% | -0.44% | – | |
TVTX | Exit | TRAVERE THERAPEUTICS INC | $0 | – | -2,118,100 | -100.0% | -0.59% | – |
ZBH | Exit | ZIMMER BIOMET HOLDINGS INC | $0 | – | -245,000 | -100.0% | -0.65% | – |
EW | Exit | EDWARDS LIFESCIENCES CORP | $0 | – | -515,000 | -100.0% | -0.88% | – |
VECT | Exit | VECTIVBIO HLDG AG | $0 | – | -5,156,561 | -100.0% | -1.59% | – |
BMY | Exit | BRISTOL-MYERS SQUIBB CO | $0 | – | -1,488,000 | -100.0% | -1.72% | – |
Other managers
Other managers that, in addition to the filing manager(s), that filed the EDGAR filing(s):
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2023-11-14
About Orbimed Advisors
Orbimed Advisors is a leading healthcare-focused investment firm that manages over $16 billion in assets. The firm was founded in 1998 by Samuel Isaly, who has over 50 years of experience in the healthcare industry. Isaly is widely regarded as a pioneer in the field of healthcare investing and has been recognized for his contributions to the industry by numerous organizations.
Orbimed Advisors has a team of over 100 professionals, including investment professionals, research analysts, and operational experts. The firm has offices in New York, San Francisco, Shanghai, and Mumbai, and invests in companies across the healthcare spectrum, including biotechnology, pharmaceuticals, medical devices, and healthcare services.
The firm's investment philosophy is based on a deep understanding of the healthcare industry and a rigorous approach to due diligence. Orbimed Advisors seeks to identify companies with innovative technologies and strong management teams that have the potential to transform the healthcare landscape.
Orbimed Advisors has a strong track record of success, with numerous successful investments in companies such as Juno Therapeutics, Spark Therapeutics, and Kite Pharma. The firm's leadership team, which includes CEO Sven Borho, COO Jonathan Silverstein, and Chief Investment Officer Carl Gordon, has decades of experience in the healthcare industry and is widely respected for their expertise and insights.
Overall, Orbimed Advisors is a leading healthcare investment firm that has a proven track record of success and a deep understanding of the healthcare industry. Investors looking to gain exposure to the healthcare sector may want to consider Orbimed Advisors as a potential investment opportunity.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
BIOGEN INC | 42 | Q3 2023 | 5.0% |
VERTEX PHARMACEUTICALS INC | 42 | Q3 2023 | 3.7% |
THERMO FISHER SCIENTIFIC INC | 42 | Q3 2023 | 3.2% |
SINOVAC BIOTECH LTD | 41 | Q3 2023 | 7.2% |
NEUROCRINE BIOSCIENCES INC | 41 | Q3 2023 | 2.7% |
BOSTON SCIENTIFIC CORP | 40 | Q3 2023 | 5.6% |
BRISTOL-MYERS SQUIBB CO | 40 | Q2 2023 | 5.2% |
AMGEN INC | 40 | Q3 2023 | 5.5% |
INTUITIVE SURGICAL INC | 40 | Q3 2023 | 3.8% |
GILEAD SCIENCES INC | 39 | Q3 2023 | 5.5% |
View Orbimed Advisors's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
Ikena Oncology, Inc. | September 21, 2023 | 2,189,111 | 5.2% |
Galecto, Inc. | September 18, 2023 | 749,557 | 2.8% |
PMV Pharmaceuticals, Inc. | August 23, 2023 | 6,563,077 | 13.5% |
Gracell Biotechnologies Inc. | August 11, 2023 | 7,641,531 | 8.0% |
Xtant Medical Holdings, Inc. | August 03, 2023 | 73,114,592 | 56.7% |
Turnstone Biologics Corp. | July 24, 2023 | 3,099,265 | 13.4% |
Passage BIO, Inc. | June 29, 2023 | 8,034,000 | 14.7% |
Prelude Therapeutics Inc | May 24, 2023 | 15,716,642 | 28.6% |
VectivBio Holding AG | May 24, 2023 | 5,156,561 | 7.7% |
Fusion Pharmaceuticals Inc. | May 16, 2023 | 2,930,670 | 4.6% |
View Orbimed Advisors's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
3 | 2024-03-27 |
SC 13D/A | 2024-03-22 |
SC 13D/A | 2024-03-21 |
SC 13D/A | 2024-03-08 |
144 | 2024-03-04 |
SC 13D/A | 2024-02-21 |
13F-HR | 2024-02-14 |
4 | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Orbimed Advisors's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.